Levels of High-Density Lipoprotein Cholesterol are Associated with Biomarkers of Inflammation in Patients with Acute Coronary Syndrome

American Journal of Cardiology

Volumn 116, Issue 11, 2015, Pages 1651-1657

  González Pacheco, Héctor ^a   Amezcua Guerra, Luis M ^a,b   Vazquez Rangel, Armando ^a   Martínez Sánchez, Carlos ^a   Pérez Méndez, Oscar ^a   Verdejo, Juan ^a   Bojalil, Rafael ^a,b  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ACUTE CORONARY SYNDROME; ACUTE PHASE RESPONSE; BLOOD; HOSPITAL MORTALITY; MIDDLE AGED; MULTIVARIATE ANALYSIS;

ACUTE CORONARY SYNDROME; ACUTE-PHASE REACTION; AGED; BIOMARKERS; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITAL MORTALITY; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SERUM ALBUMIN;

EID: 84947489171     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.09.009     Document Type: Article

References (28)

1. E.F. Borba, and E. Bonfá Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies Lupus 6 1997 533 539
2. J. Robertson, M.J. Peters, I.B. McInnes, and N. Sattar Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm Nat Rev Rheumatol 9 2013 513 523
3. V.G. Cabana, S.S. Gidding, G.S. Getz, J. Chapman, and S.T. Shulman Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease Pediatr Res 42 1997 651 655
4. V.P. van Halm, J.C. van Denderen, M.J. Peters, J.W. Twisk, M. van der Paardt, I.E. van der Horst-Bruinsma, R.J. van de Stadt, M.H. de Koning, B.A. Dijkmans, and M.T. Nurmohamed Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis Ann Rheum Dis 65 2006 1473 1477
5. B.R. Gordon, T.S. Parker, D.M. Levine, S.D. Saal, J.C. Wang, B.J. Sloan, P.S. Barie, and A.L. Rubin Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients Crit Care Med 29 2001 1563 1568
6. B.R. Gordon, T.S. Parker, D.M. Levine, S.D. Saal, J.C. Wang, B.J. Sloan, P.S. Barie, and A.L. Rubin Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia Crit Care Med 24 1996 584 589
7. M.J. Haas, and A.D. Mooradian Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease Diabetes Metab Res Rev 26 2010 90 99
8. C.P. Cannon, A. Battler, R.G. Brindis, J.L. Cox, S.G. Ellis, N.R. Every, J.T. Flaherty, R.A. Harrington, H.M. Krumholz, M.L. Simoons, F.J. Van De Werf, W.S. Weintraub, K.R. Mitchell, S.L. Morrisson, R.G. Brindis, H.V. Anderson, D.S. Cannom, W.R. Chitwood, J.E. Cigarroa, R.L. Collins-Nakai, S.G. Ellis, R.J. Gibbons, F.L. Grover, P.A. Heidenreich, B.K. Khandheria, S.B. Knoebel, H.L. Krumholz, D.J. Malenka, D.B. Mark, C.R. Mckay, E.R. Passamani, M.J. Radford, R.N. Riner, J.B. Schwartz, R.E. Shaw, R.J. Shemin, D.B. Van Fossen, E.D. Verrier, M.W. Watkins, D.R. Phoubandith, and T. Furnelli American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee) J Am Coll Cardiol 38 2001 2114 2130
9. C. Gabay, and I. Kushner Acute-phase proteins and other systemic responses to inflammation N Engl J Med 340 1999 448 454
10. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
11. C. Heeschen, C.W. Hamm, J. Bruemmer, and M.L. Simoons Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial J Am Coll Cardiol 35 2000 1535 1542
12. M.I. Furman, J.M. Gore, F.A. Anderson, A. Budaj, S.G. Goodman, A. Avezum, J. López-Sendón, W. Klein, D. Mukherjee, K.A. Eagle, O.H. Dabbous, R.J. Goldberg GRACE Investigators Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE) Am Heart J 147 2004 42 48
13. V. Oduncu, A. Erkol, C.Y. Karabay, M. Kurt, T. Akgün, M. Bulut, S. Pala, and C. Kirma The prognostic value of serum albumin levels on admission in patients with acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention Coron Artery Dis 24 2013 88 94
14. M.T. Roe, F.S. Ou, K.P. Alexander, L.K. Newby, J.M. Foody, W.B. Gibler, W.E. Boden, E.M. Ohman, S.C. Smith Jr., and E.D. Peterson Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes Eur Heart J 298 2008 2480 2488
15. S. Acharjee, M.T. Roe, E.A. Amsterdam, D.N. Holmes, and W.E. Boden Relation of admission high-density lipoprotein cholesterol level and in-hospital mortality in patients with acute non-ST segment elevation myocardial infarction (from the National Cardiovascular Data Registry) Am J Cardiol 112 2013 1057 1062
16. B. Pitt, J. Loscalzo, J. Ycas, and J.S. Raichlen Lipid levels after acute coronary syndromes J Am Coll Cardiol 51 2008 1440 1445
17. M. Navab, J.A. Berliner, G. Subbanagounder, S. Hama, A.J. Lusis, L.W. Castellani, S. Reddy, D. Shih, W. Shi, A.D. Watson, B.J. Van Lenten, D. Vora, and A.M. Fogelman HDL and the inflammatory response induced by LDL-derived oxidized phospholipids Arterioscler Thromb Vasc Biol 21 2001 481 488
18. S. Akgün, N.H. Ertel, A. Mosenthal, and W. Oser Postsurgical reduction of serum lipoproteins: interleukin-6 and the acute-phase response J Lab Clin Med 131 1998 103 108
19. M.H. Bentz, and J. Magnette Hypocholesterolemia during the acute phase of an inflammatory reaction of infectious origin. 120 cases Rev Med Interne 19 1998 168 172
20. P. Fraunberger, G. Pilz, P. Cremer, K. Werdan, and A.K. Walli Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock Shock 10 1998 359 363
21. J.Y. Chien, J.S. Jerng, C.J. Yu, and P.C. Yang Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis Crit Care Med 33 2005 1688 1693
22. F. Schiele, N. Meneveau, M.F. Seronde, R. Chopard, V. Descotes-Genon, J. Dutheil, J.P. Bassand Reseau de Cardiologie de Franche Comte C-reactive protein improves risk prediction in patients with acute coronary syndromes Eur Heart J 31 2010 290 297
23. B.J. Van Lenten, S.T. Reddy, M. Navab, and A.M. Fogelman Understanding changes in high density lipoproteins during the acute phase response Arterioscler Thromb Vasc Biol 26 2006 1687 1688
24. M. Navab, G.M. Anantharamaiah, and A.M. Fogelman The role of high-density lipoprotein in inflammation Trends Cardiovasc Med 15 2005 158 161
25. K. Alwaili, D. Bailey, Z. Awan, S.D. Bailey, I. Ruel, A. Hafiane, L. Krimbou, S. Laboissiere, and J. Genest The HDL proteome in acute coronary syndromes shifts to an inflammatory profile Biochim Biophys Acta 1821 2012 405 415
26. A.C. Morton, A.M. Rothman, J.P. Greenwood, J. Gunn, A. Chase, B. Clarke, A.S. Hall, K. Fox, C. Foley, W. Banya, D. Wang, M.D. Flather, and D.C. Crossman The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study Eur Heart J 36 2015 377 384
27. G.G. Schwartz, A.G. Olsson, M. Abt, C.M. Ballantyne, P.J. Barter, J. Brumm, B.R. Chaitman, I.M. Holme, D. Kallend, L.A. Leiter, E. Leitersdorf, J.J. McMurray, H. Mundl, S.J. Nicholls, P.K. Shah, J.C. Tardif, R.S. Wright dal-OUTCOMES Investigators Effects of dalcetrapib in patients with a recent acute coronary syndrome N Engl J Med 367 2012 2089 2099
28. D.M. Tehrani, J.M. Gardin, D. Yanez, C.H. Hirsch, D.M. Lloyd-Jones, P.K. Stein, and N.D. Wong Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: Cardiovascular Health Study Atherosclerosis 231 2013 246 251